1. Home
  2. CAG vs GKOS Comparison

CAG vs GKOS Comparison

Compare CAG & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ConAgra Brands Inc.

CAG

ConAgra Brands Inc.

HOLD

Current Price

$15.75

Market Cap

7.5B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$104.82

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAG
GKOS
Founded
1919
1998
Country
United States
United States
Employees
26100
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CAG
GKOS
Price
$15.75
$104.82
Analyst Decision
Hold
Strong Buy
Analyst Count
14
14
Target Price
$18.86
$133.07
AVG Volume (30 Days)
13.6M
598.4K
Earning Date
04-01-2026
04-29-2026
Dividend Yield
8.90%
N/A
EPS Growth
233.33
N/A
EPS
N/A
N/A
Revenue
$1,500,000,000.00
$507,442,000.00
Revenue This Year
N/A
$23.34
Revenue Next Year
N/A
$27.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.33
52 Week Low
$15.04
$73.16
52 Week High
$27.68
$130.23

Technical Indicators

Market Signals
Indicator
CAG
GKOS
Relative Strength Index (RSI) 37.79 45.83
Support Level N/A $81.54
Resistance Level $19.54 $104.66
Average True Range (ATR) 0.52 4.10
MACD -0.05 0.57
Stochastic Oscillator 32.39 61.22

Price Performance

Historical Comparison
CAG
GKOS

About CAG ConAgra Brands Inc.

Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: